[1] |
Sung H, Ferlay J, Siegel R L, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021,71:209-249.
|
[2] |
Lamb A, Chen L F. Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer[J]. J Cell Biochem, 2013,114:491-497.
|
[3] |
Ren S, Cai P, Liu Y, et al. Prevalence of Helicobacter pylori infection in China: a systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2022,37:464-470.
|
[4] |
Cho J, Prashar A, Jones N L, et al. Helicobacter pylori infection[J]. Gastroenterol Clin North Am, 2021,50:261-282.
|
[5] |
van Den Brink GR, Ten KF, Ponsioen CY, et al. Expression and activation of NF-kappa B in the antrum of the human stomach[J]. J Immunol, 2000,164:3353-3359.
|
[6] |
Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark[J]. Mol Cell, 2007,25:15-30.
|
[7] |
Luscher-Firzlaff J, Gawlista I, Vervoorts J, et al. The human trithorax protein hASH2 functions as an oncoprotein[J]. Cancer Res, 2008,68:749-758.
|
[8] |
Li T, Fan J, Wang B, et al. TIMER: a Web server for comprehensive analysis of tumor-infiltrating immune cells[J]. Cancer Res, 2017,77:e108-e110.
|
[9] |
Chandrashekar DS, Bashel B, Balasubramanya S, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses[J]. Neoplasia, 2017,19:649-658.
|
[10] |
Yang Z, Xie C, Xu W, et al. Phosphorylation and inactivation of PTEN at residues Ser380/Thr382/383 induced by Helicobacter pylori promotes gastric epithelial cell survival through PI3K/Akt pathway[J]. Oncotarget, 2015,6:31916-31926.
|
[11] |
Johnston FM, Beckman M. Updates on management of gastric cancer[J]. Curr Oncol Rep, 2019,21:67.doi:10.1007/s11912-019-0820-4.
|
[12] |
Zeng K, Wu Y, Wang C, et al. ASH2L is involved in promotion of endometrial cancer progression via upregula-tion of PAX2 transcription[J]. Cancer Sci, 2020,111:2062-2077.
|
[13] |
Constantin D, Widmann C. ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin's lymphoma and testicular cancer cells[J]. Cell Death Dis, 2020,11:1019.doi:10.1038/s41419-020-03231-0.
|
[14] |
Butler JS, Qiu YH, Zhang N, et al. Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia[J]. Leuk Lymphoma, 2017,58:1207-1218.
|
[15] |
Dou Y, Milne TA, Ruthenburg AJ, et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components[J]. Nat Struct Mol Biol, 2006,13:713-719.
|